{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:39:15Z","timestamp":1790843955577,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,8,11]],"date-time":"2010-08-11T00:00:00Z","timestamp":1281484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2334-10-238","type":"journal-article","created":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T12:51:30Z","timestamp":1468068690000},"source":"Crossref","is-referenced-by-count":32,"title":["Determinants of seropositivity among HPV-16\/18 DNA positive young women"],"prefix":"10.1186","volume":"10","author":[{"name":"the Costa Rica HPV Vaccine Trial (CVT) Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Porras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboobeh","family":"Safaeian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Coseo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cecilia","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sholom","family":"Wacholder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen-Jan","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Bougelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Quint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Hildesheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,11]]},"reference":[{"key":"1218_CR1","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1086\/315498","volume":"181","author":"JJ Carter","year":"2000","unstructured":"Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N, Galloway DA: Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis. 2000, 181: 1911-1919. 10.1086\/315498.","journal-title":"J Infect Dis"},{"key":"1218_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1158\/1055-9965.EPI-03-0191","volume":"13","author":"GY Ho","year":"2004","unstructured":"Ho GY, Studentsov YY, Bierman R, Burk RD: Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Cancer Epidemiol Biomarkers Prev. 2004, 13: 110-116. 10.1158\/1055-9965.EPI-03-0191.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl 2","key":"1218_CR3","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/S1201-9712(07)60016-2","volume":"11","author":"I Frazer","year":"2007","unstructured":"Frazer I: Correlating immunity with protection for HPV infection. Int J Infect Dis. 2007, 11 (Suppl 2): S10-16. 10.1016\/S1201-9712(07)60016-2.","journal-title":"Int J Infect Dis"},{"issue":"Suppl 1","key":"1218_CR4","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.vaccine.2005.09.002","volume":"24","author":"M Stanley","year":"2006","unstructured":"Stanley M: Immune responses to human papillomavirus. Vaccine. 2006, 24 (Suppl 1): S16-22. 10.1016\/j.vaccine.2005.09.002.","journal-title":"Vaccine"},{"key":"1218_CR5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1258\/095646203321264872","volume":"14","author":"B Nonnenmacher","year":"2003","unstructured":"Nonnenmacher B, Pintos J, Bozzetti MC, Mielzinska-Lohnas I, Lorincz AT, Ikuta N, Schwartsmann G, Villa LL, Schiller JT, Franco E: Epidemiologic correlates of antibody response to human papillomavirus among women at low risk of cervical cancer. Int J STD AIDS. 2003, 14: 258-265. 10.1258\/095646203321264872.","journal-title":"Int J STD AIDS"},{"key":"1218_CR6","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1086\/344354","volume":"186","author":"KM Stone","year":"2002","unstructured":"Stone KM, Karem KL, Sternberg MR, McQuillan GM, Poon AD, Unger ER, Reeves WC: Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis. 2002, 186: 1396-1402. 10.1086\/344354.","journal-title":"J Infect Dis"},{"key":"1218_CR7","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/sj.bjc.6601272","volume":"89","author":"SS Wang","year":"2003","unstructured":"Wang SS, Schiffman M, Shields TS, Herrero R, Hildesheim A, Bratti MC, Sherman ME, Rodriguez AC, Castle PE, Morales J, et al: Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa Rica. Br J Cancer. 2003, 89: 1248-1254. 10.1038\/sj.bjc.6601272.","journal-title":"Br J Cancer"},{"key":"1218_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ejogrb.2005.02.001","volume":"124","author":"P Naud","year":"2006","unstructured":"Naud P, Matos J, Hammes L, Stuckzynski J, Brouwers K, Magno V, Dias E, Crusius P, d'Avila A, Campos C, et al: Factors predicting intermediate endpoints of cervical cancer and exposure to human papillomavirus (HPV) infections in young women screened as potential targets for prophylactic HPV vaccination in south of Brazil. Eur J Obstet Gynecol Reprod Biol. 2006, 124: 110-118. 10.1016\/j.ejogrb.2005.02.001.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1218_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/ijc.10825","volume":"103","author":"HR Shin","year":"2003","unstructured":"Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, Jung KY, Kim HH, Park UD, Cha HS, et al: Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer. 2003, 103: 413-421. 10.1002\/ijc.10825.","journal-title":"Int J Cancer"},{"key":"1218_CR10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1128\/CDLI.4.2.122-126.1997","volume":"4","author":"RP Viscidi","year":"1997","unstructured":"Viscidi RP, Kotloff KL, Clayman B, Russ K, Shapiro S, Shah KV: Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women. Clin Diagn Lab Immunol. 1997, 4: 122-126.","journal-title":"Clin Diagn Lab Immunol"},{"key":"1218_CR11","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1016\/j.vaccine.2008.07.002","volume":"26","author":"R Herrero","year":"2008","unstructured":"Herrero R, Hildesheim A, Rodriguez AC, Wacholder S, Bratti C, Solomon D, Gonzalez P, Porras C, Jimenez S, Guillen D, et al: Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica. Vaccine. 2008, 26: 4795-4808. 10.1016\/j.vaccine.2008.07.002.","journal-title":"Vaccine"},{"key":"1218_CR12","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1128\/JCM.00620-08","volume":"46","author":"PE Castle","year":"2008","unstructured":"Castle PE, Porras C, Quint WG, Rodriguez AC, Schiffman M, Gravitt PE, Gonzalez P, Katki HA, Silva S, Freer E, et al: Comparison of two PCR-based human papillomavirus genotyping methods. J Clin Microbiol. 2008, 46: 3437-3445. 10.1128\/JCM.00620-08.","journal-title":"J Clin Microbiol"},{"key":"1218_CR13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1128\/JCM.34.3.745-747.1996","volume":"34","author":"MF Baay","year":"1996","unstructured":"Baay MF, Quint WG, Koudstaal J, Hollema H, Duk JM, Burger MP, Stolz E, Herbrink P: Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol. 1996, 34: 745-747.","journal-title":"J Clin Microbiol"},{"key":"1218_CR14","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1128\/JCM.00539-06","volume":"44","author":"LJ van Doorn","year":"2006","unstructured":"van Doorn LJ, Molijn A, Kleter B, Quint W, Colau B: Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J Clin Microbiol. 2006, 44: 3292-3298. 10.1128\/JCM.00539-06.","journal-title":"J Clin Microbiol"},{"key":"1218_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.4161\/hv.4.6.6912","volume":"4","author":"FJ Dessy","year":"2008","unstructured":"Dessy FJ, Giannini SL, Bougelet CA, Kemp TJ, David MP, Poncelet SM, Pinto LA, Wettendorff MA: Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16\/18 cervical cancer vaccine. Hum Vaccin. 2008, 4: 425-434.","journal-title":"Hum Vaccin"},{"key":"1218_CR16","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","volume":"364","author":"DM Harper","year":"2004","unstructured":"Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS, et al: Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet. 2004, 364: 1757-1765. 10.1016\/S0140-6736(04)17398-4.","journal-title":"Lancet"},{"key":"1218_CR17","volume-title":"Sex Transm Dis","author":"S Coseo","year":"2009","unstructured":"Coseo S, Porras C, Hildesheim A, Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Gonzalez P, Wang SS, Sherman ME, et al: Seroprevalence and Determinants of Human Papillomavirus 16\/18 Seropositivity among Young Women in Costa Rica. Sex Transm Dis. 2009"},{"key":"1218_CR18","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ijc.10868","volume":"103","author":"EM de Villiers","year":"2003","unstructured":"de Villiers EM: Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma. Int J Cancer. 2003, 103: 705-708. 10.1002\/ijc.10868.","journal-title":"Int J Cancer"},{"key":"1218_CR19","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/sj.bjc.6600971","volume":"88","author":"J Green","year":"2003","unstructured":"Green J, de Gonzalez Berrington A, Smith JS, Franceschi S, Appleby P, Plummer M, Beral V: Human papillomavirus infection and use of oral contraceptives. Br J Cancer. 2003, 88: 1713-1720. 10.1038\/sj.bjc.6600971.","journal-title":"Br J Cancer"},{"key":"1218_CR20","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1158\/1055-9965.EPI-07-0349","volume":"16","author":"GM Clifford","year":"2007","unstructured":"Clifford GM, Shin HR, Oh JK, Waterboer T, Ju YH, Vaccarella S, Quint W, Pawlita M, Franceschi S: Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea. Cancer Epidemiol Biomarkers Prev. 2007, 16: 1874-1879. 10.1158\/1055-9965.EPI-07-0349.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1218_CR21","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1158\/1055-9965.EPI-07-2796","volume":"17","author":"B Dondog","year":"2008","unstructured":"Dondog B, Clifford GM, Vaccarella S, Waterboer T, Unurjargal D, Avirmed D, Enkhtuya S, Kommoss F, Wentzensen N, Snijders PJ, et al: Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol Biomarkers Prev. 2008, 17: 1731-1738. 10.1158\/1055-9965.EPI-07-2796.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1218_CR22","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.humpath.2007.12.002","volume":"39","author":"MB Kovacic","year":"2008","unstructured":"Kovacic MB, Katki HA, Kreimer AR, Sherman ME: Epidemiologic analysis of histologic cervical inflammation: relationship to human papillomavirus infections. Hum Pathol. 2008, 39: 1088-1095. 10.1016\/j.humpath.2007.12.002.","journal-title":"Hum Pathol"},{"key":"1218_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1086\/596060","volume":"199","author":"M Safaeian","year":"2009","unstructured":"Safaeian M, Falk RT, Rodriguez AC, Hildesheim A, Kemp T, Williams M, Morera L, Barrantes M, Herrero R, Porras C, Pinto L: Factors associated with fluctuations in IgA and IgG levels at the cervix during the menstrual cycle. J Infect Dis. 2009, 199: 455-463. 10.1086\/596060.","journal-title":"J Infect Dis"},{"key":"1218_CR24","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/infdis\/174.5.937","volume":"174","author":"L Wideroff","year":"1996","unstructured":"Wideroff L, Schiffman MH, Hoover R, Tarone RE, Nonnenmacher B, Hubbert N, Kirnbauer R, Greer CE, Lorincz AT, Manos MM, et al: Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and-negative women. J Infect Dis. 1996, 174: 937-943.","journal-title":"J Infect Dis"},{"key":"1218_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/sj.bjc.6602915","volume":"94","author":"S Bulk","year":"2006","unstructured":"Bulk S, Berkhof J, Bulkmans NW, Zielinski GD, Rozendaal L, van Kemenade FJ, Snijders PJ, Meijer CJ: Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands. Br J Cancer. 2006, 94: 171-175. 10.1038\/sj.bjc.6602915.","journal-title":"Br J Cancer"},{"key":"1218_CR26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.virol.2005.04.002","volume":"337","author":"M Schiffman","year":"2005","unstructured":"Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, Bratti MC, Sherman ME, Morales J, Guillen D, et al: The carcinogenicity of human papillomavirus types reflects viral evolution. Virology. 2005, 337: 76-84. 10.1016\/j.virol.2005.04.002.","journal-title":"Virology"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-10-238\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-238.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-238.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T18:36:46Z","timestamp":1600886206000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-10-238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,11]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1218"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-10-238","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,11]]},"article-number":"238"}}